Cypher Versus Taxus: All Smoke and No Fire: Lessons for Future Comparative Drug-Eluting Stent Trials in Interventional Cardiology

American Journal of Cardiology

Volumn 99, Issue 3, 2007, Pages 424-427

  Buch, Ashesh N ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ELUTING STENT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; RESTENOSIS; SAFETY; SYSTEMATIC REVIEW; THROMBOSIS;

EID: 33846412986     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.08.049     Document Type: Note

References (19)

1. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., and Stoll H.P. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904
2. Windecker S., Remondino A., Eberli F.R., Juni P., Raber L., Wenaweser P., Togni M., Billinger M., Tuller D., Seiler C., et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353 (2005) 653-662
3. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., and Schomig A. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
4. Goy J.J., Stauffer J.C., Siegenthaler M., Benoit A., and Seydoux C. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial. J Am Coll Cardiol 45 (2005) 308-311
5. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von Beckerath N., Ulm K., Wessely R., Dirschinger J., and Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
6. Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., and Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27 (2006) 260-266
7. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
8. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
9. Ruygrok P.N., Melkert R., Morel M.A., Ormiston J.A., Bar F.W., Fernandez-Aviles F., Suryapranata H., Dawkins K.D., Hanet C., Serruys P.W., and Benestent II Investigators. Does angiography six months after coronary intervention influence management and outcome?. J Am Coll Cardiol 34 (1999) 1507-1511
10. Hermiller J.B., Raizner A., Cannon L., Gurbel P.A., Kutcher M.A., Wong S.C., Russell M.E., Ellis S.G., Mehran R., and Stone G.W. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1172-1179
11. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., and Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
12. Schampaert E., Cohen E.A., Schluter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., and Popma J.J. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
13. Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 292 (2004) 2727-2734
14. Ong A.T., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Valgimigli M., Tsuchida K., Sonnenschein K., Regar E., van der Giessen W.J., de Jaegere P.P., et al. Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). Am J Cardiol 96 (2005) 358-362
15. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlman P., Seung-woon R., Clavijo L.C., Sang-wook K., Bui A.B., Gevorkian N., Xue Z., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
16. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
17. Rogers C., and Edelman E.R. Pushing drug-eluting stents into uncharted territory: simpler than you think-more complex than you imagine. Circulation 113 (2006) 2262-2265
18. Kastrati A., Dibra A., Mehilli J., Mayer S., Pinieck S., Pache J., Dirschinger J., and Schomig A. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113 (2006) 2293-2300
19. Kastrati A., Dibra A., Eberle S., Mehilli J., Suarez de Lezo J., Goy J.J., Ulm K., and Schomig A. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 294 (2005) 819-825